Senna glycosides or sennosides

Vasoactive Intestinal Peptide Fragment 1-12 human, porcine, rat.

InformationTrametinib (GSK1120212, JTP-74057, Mekinist) DMSO solvate is a highly specific and potentMEK1/2inhibitor with IC50 of 0.92 nM/1.8 nM in cell-free assay. Trametinib activatesautophagyand inducesapoptosis.TargetsMEK1 (Cell-free assay): MEK2

InformationTrametinib (GSK1120212, JTP-74057, Mekinist) DMSO solvate is a highly specific and potentMEK1/2inhibitor with IC50 of 0.92 nM/1.8 nM in cell-free assay. Trametinib activatesautophagyand inducesapoptosis.TargetsMEK1 (Cell-free assay): MEK2

InformationTrametinib (GSK1120212, JTP-74057, Mekinist) DMSO solvate is a highly specific and potentMEK1/2inhibitor with IC50 of 0.92 nM/1.8 nM in cell-free assay. Trametinib activatesautophagyand inducesapoptosis.TargetsMEK1 (Cell-free assay): MEK2

InformationTrametinib (GSK1120212, JTP-74057, Mekinist) DMSO solvate is a highly specific and potentMEK1/2inhibitor with IC50 of 0.92 nM/1.8 nM in cell-free assay. Trametinib activatesautophagyand inducesapoptosis.TargetsMEK1 (Cell-free assay): MEK2

InformationTrametinib (GSK1120212, JTP-74057, Mekinist) DMSO solvate is a highly specific and potentMEK1/2inhibitor with IC50 of 0.92 nM/1.8 nM in cell-free assay. Trametinib activatesautophagyand inducesapoptosis.TargetsMEK1 (Cell-free assay): MEK2

InformationTrametinib (GSK1120212, JTP-74057, Mekinist) DMSO solvate is a highly specific and potentMEK1/2inhibitor with IC50 of 0.92 nM/1.8 nM in cell-free assay. Trametinib activatesautophagyand inducesapoptosis.TargetsMEK1 (Cell-free assay): MEK2

Sennoside A.

PDGF inhibitor.

Senegenin.

Seneciphynine.

PDGF inhibitor.